Johanna Sagemark

Johanna is a safety bioinformatician in the Data Science and AI group within Drug Safety and Metabolism at AstraZeneca. Drug design is a multiparameter optimization problem that requires a fine balance between potency, ADME, and safety. Data science and artificial intelligence are potential methods to both improve the safety profile of new drugs as well as reduce the costs and time to bring these to the clinic, and in her talk, Johanna will exemplify its application within drug safety.